Data integration workflow for search of disease driving genes and genetic variants

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Karinen, Sirkku ^a   Heikkinen, Tuomas ^b   Nevanlinna, Heli ^b   Hautaniemi, Sampsa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CANCER SURVIVAL; CANDIDATE GENES AND SNP; CCDC26 GENE; CDKN2A GENE; CDKN2B GENE; CONTROLLED STUDY; DNA INTEGRATION; GENE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC PARAMETERS; GENETIC RISK; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; P53 GENE; PHLDB1 GENE; PROTEIN PROTEIN INTERACTION; RTEL1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; TUMOR GENE; BRAIN TUMOR; GENETICS; SURVIVAL; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; GENES, P53; GENETIC VARIATION; GLIOBLASTOMA; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS;

EID: 79954530516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018636     Document Type: Article

References (40)

1. Savas S, Geraci J, Jurisica I, Liu G, (2009) A comprehensive catalogue of functional genetic variations in the EGFR pathway: Protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research. International Journal of Cancer 125: 1257-65.
2. Thomas DC, (2005) The need for a systematic approach to complex pathways in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14: 557-559.
3. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
4. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
5. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nature Genetics 41: 899-904.
6. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: 480-484.
7. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37: 619-622.
8. Wu J, Vallenius T, Ovaska K, Westermarck J, Mäkelä TP, et al. (2009) Integrated network analysis platform for protein-protein interactions. Nat Methods 6: 75-77.
9. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, et al. (2009) Ensembl 2009. Nucleic Acids Res 37: 690-697.
10. International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796.
11. Sunyaev S, Ramensky V, Koch I, Lathe W, Kondrashov AS, et al. (2001) Prediction of deleterious human alleles. Hum Mol Genet 10: 591-597.
12. Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nature Methods 7: 248-249.
13. Yue P, Moult J, (2006) Identification and analysis of deleterious human SNPs. J Mol Biol 356: 1263-1274.
14. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
15. Karchin R, (2009) Next generation tools for the annotation of human SNPs. Brief Bioinform 10: 35-52.
16. Pico AR, Smirnov IV, Chang JS, Yeh RF, Wiemels JL, et al. (2009) SNPLogic: an interactive single nucleotide polymorphism selection, annotation, and prioritization system. Nucleic Acids Res 37: 803-809.
17. Wang P, Dai M, Xuan W, McEachin RC, Jackson AU, et al. (2006) SNP Function Portal: a web database for exploring the function implication of SNP alleles. Bioinformatics 22: 523-529.
18. Xu Z, Taylor JA, (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37: 600-605.
19. Li S, Ma L, Li H, Vang S, Hu Y, et al. (2007) Snap: an integrated SNP annotation platform. Nucleic Acids Res 35: 707-710.
20. Lee PH, Shatkay H, (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36: 820-824.
21. Calabria A, Mosca E, Viti F, Merelli I, Milanesi L, (2010) SNPRanker: a tool for identification and scoring of SNPs associated to target genes. Journal of Integrative Bioinformatics 7: 138.
22. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, et al. (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Medicine 2: 65.
23. Barrett J, Cardon L, (2006) Evaluating coverage of genome-wide association studies. Nature Genetics 38: 659-662.
24. Risch N, (2000) Searching for genetic determinants in the new millennium. Nature 405: 847-856.
25. Pim D, Banks L, (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108: 196-199.
26. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, et al. (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100.
27. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, et al. (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141.
28. Siddique MM, Balram C, Fiszer-Maliszewska L, Aggarwal A, Tan A, et al. (2005) Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development. Cancer Epidemiol Biomarkers Prev 14: 2245-2252.
29. Schmidt MK, Tommiska J, Broeks A, van Leeuwen FE, Van't Veer LJ, et al. (2009) Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients. Breast Cancer Res 11.
30. Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, et al. (2005) Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 11: 5098-5103.
31. Yu K, Zhang J, Zhang J, Dou C, Gu S, et al. (2009) Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet.
32. Weber RG, Rieger J, Naumann U, Lichter P, Weller M, (2001) Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines. Int J Cancer 91: 213-218.
33. Glinsky GV, (2006) Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 5: 1208-1216.
34. Aaltonen K, Amini RM, Heikkilä P, Aittomäki K, Tamminen A, et al. (2009) High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer 100: 1055-1060.
35. Souza-Rodrígues E, Estanyol JM, Friedrich-Heineken E, Olmedo E, Vera J, et al. (2007) Proteomic analysis of p16ink4a-binding proteins. Proteomics 7: 4102-4111.
36. Hermeking H, Benzinger A, (2006) 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 16: 183-192.
37. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
38. Haider S, Ballester B, Smedley D, Zhang J, Rice P, et al. (2009) BioMart Central Portal-unified access to biological data. Nucleic acids research.
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-75.
40. Carvalho B, Bengtsson H, Speed TP, Irizarry RA, (2007) Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data. Biostatistics 8: 485-499.